ZeptoMetrix® is thrilled to present PROtrol TM, an innovative range of products specifically designed for antigen-based diagnostic methods. These meticulously developed third-party materials serve as faithful clinical specimen surrogates and offer a means to assess and monitor the efficacy of antigen-based assays, particularly lateral flow immunoassays employed in the detection of infectious diseases.
PROtrol stands out as the sole whole organism reference material that provides comprehensive testing data. Each product lot is accompanied by crucial information, including protein concentration and TCID50 value, effectively reducing the need for extensive qualification testing. By enhancing reproducibility, PROtrol optimizes resource allocation and processing time, significantly reducing the necessity for repeated testing.
Dr. Karuna Sharma, Vice President & Chief Scientific Officer, commented, “The rapid growth of antigen-based assays has underscored certain quality challenges. Inactivated, whole organism controls designed specifically for antigen tests empower manufacturers with the necessary tools to evaluate assay performance, resulting in higher-quality tests in the market.”
The first member of this product line, PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* (PROSARS(COV2)-587), addresses the current COVID-19 pandemic. ZeptoMetrix is committed to expanding the PROtrol product line beyond this crisis, ensuring the provision of high-quality controls to assay manufacturers striving to widen access to affordable and user-friendly diagnostics.
Evangeline Gonzalez, President of Antylia Diagnostics division, remarked, “The launch and expansion of PROtrol strengthen our position as the preferred partner for diagnostic test developers. As we collaborate with our diagnostic partners, ZeptoMetrix takes pride in the role PROtrol plays in extending global access to diagnostic testing, benefiting patients worldwide.”
For detailed information on how to order the new PROtrol and explore additional ZeptoMetrix products, please visit: https://www.zeptometrix.com
About ZeptoMetrix® ZeptoMetrix® enjoys a prominent standing as a respected industry leader, dedicated to designing, developing, and delivering innovative and reliable solutions for the infectious disease diagnostics market. With expertise in molecular diagnostics, encompassing external quality controls, verification panels, proficiency panels, and customized/OEM products and services, ZeptoMetrix sets the industry benchmark for performance and dependability, making it the preferred choice for independent third-party quality control materials.
Contact Information
Andrew Zenger
Global Product Manager
andrew.zenger@antylia.com
(716) 715-7417
The post ZeptoMetrix Unveils PROtrol: Ensuring Quality Control for the Lateral Flow Immunoassay Sector first appeared on BusinessMole.